Aldeyra Therapeutics's total assets for Q1 2026 were $66.48T, an increase of 92261503.03% from the previous quarter. ALDX total liabilities were $24.33T for the fiscal quarter, a 87476446.65% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.